Treatment Resistant Cancers
Cancer Survival Analysis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Roxane D Staiger1, Birgit Helmchen, Claudia Papet
1*Research Fellow, Department of Visceral- and Transplant Surgery, University Hospital of Zurich, Zurich, Switzerland; †Senior Physician, Department of Pathology, Triemli Hospital, Zurich, Switzerland; ‡Senior Physician, Department of Oncology, Limmattal Hospital, Zurich-Schlieren, Switzerland; §Senior Physician, Department of Surgery, Limmattal Hospital, Zurich-Schlieren, Switzerland; and ¶Director and Chief Physician, Department of Surgery, Limmattal Hospital, Zurich-Schlieren, Switzerland.
Spiradenocarcinomas (SCs) are rare skin tumors. Radical excision with clear margins and lymph node resection, combined with imaging for staging and frequent follow-up, improves outcomes for these aggressive cancers.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: